<DOC>
	<DOCNO>NCT00481390</DOCNO>
	<brief_summary>This study cross-sectional observational study evaluate prevalence HLA-B*5701 European area major European ethnotypes . Any HIV-1 infected patient eligible study include treatment na√Øve experience patient , well patient previously test HLA-B*5701 . Patients approached standard clinic visit , consent prior study specific procedure . They ask provide tissue sample ( cheek cell blood sample ) use assess HLA-B*5701 status local central laboratory . In select site patient may ask provide additional blood sample . This sample use develop validate different methodology assess HLA-B*5701 status .</brief_summary>
	<brief_title>Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion criterion : HIV1 infect patient age 18 year Patient willing able understand provide write informed consent Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>HLA-B*5701</keyword>
	<keyword>prevalence</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>